These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33507832)

  • 1. Reading Comprehension Impairment in Children With Neurofibromatosis Type 1 (NF1): The Need of Multimodal Assessment of Attention.
    Biotteau M; Tournay E; Baudou E; Destarac S; Iannuzzi S; Faure-Marie N; Castelnau P; Schweitzer E; Rodriguez D; Kemlin I; Dorison N; Rivier F; Carneiro M; Preclaire E; Barbarot S; Lauwers-Cancès V; Chaix Y
    J Child Neurol; 2021 Jul; 36(8):625-634. PubMed ID: 33507832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficit in phonological processes: a characteristic of the neuropsychological profile of children with NF1.
    Chaix Y; Lauwers-Cancès V; Faure-Marie N; Gentil C; Lelong S; Schweitzer E; Rodriguez D; Iannuzzi S; Kemlin I; Dorison N; Rivier F; Carniero M; Preclaire E; Barbarot S; Lion-François L; Castelnau P
    Child Neuropsychol; 2018 May; 24(4):558-574. PubMed ID: 28393676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor dysfunction in NF1: Mediated by attention deficit or inherent to the disorder?
    Haas-Lude K; Heimgärtner M; Winter S; Mautner VF; Krägeloh-Mann I; Lidzba K
    Eur J Paediatr Neurol; 2018 Jan; 22(1):164-169. PubMed ID: 29111114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.
    Lorenzo J; Barton B; Arnold SS; North KN
    J Pediatr; 2013 Nov; 163(5):1479-83.e1. PubMed ID: 23910685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual-processing deficits in children with neurofibromatosis type 1: A clinical marker of reading difficulties.
    Vernet M; Jover M; Bellocchi S; Maziero S; Jucla M; Tallet J; Danna J; Chaix Y; Ducrot S
    Eur J Paediatr Neurol; 2022 May; 38():25-32. PubMed ID: 35381410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling the Word Reading Abilities of School-Age Children with Neurofibromatosis Type 1.
    Arnold SS; Payne JM; McArthur G; North KN; Barton B
    J Int Neuropsychol Soc; 2021 May; 27(5):484-496. PubMed ID: 33190672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.
    Haebich KM; Pride NA; Walsh KS; Chisholm A; Rouel M; Maier A; Anderson V; Barton B; Silk T; Korgaonkar M; Seal M; Lami F; Lorenzo J; Williams K; Dabscheck G; Rae CD; Kean M; North KN; Payne JM
    BMJ Open; 2019 Sep; 9(9):e030601. PubMed ID: 31558455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of ADHD in neurofibromatosis type 1.
    Mautner VF; Kluwe L; Thakker SD; Leark RA
    Dev Med Child Neurol; 2002 Mar; 44(3):164-70. PubMed ID: 12005317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of performance of children with neurofibromatosis type 1 on the K-CPT and K-CPT 2.
    Pardej SK; Glad DM; Lee KM; Casnar CL; Klein-Tasman BP
    Child Neuropsychol; 2022 Jul; 28(5):701-708. PubMed ID: 35168479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is executive function specifically impaired in children with neurofibromatosis type 1? A neuropsychological investigation of cognitive flexibility.
    Roy A; Barbarot S; Roulin JL; Charbonnier V; Fasotti L; Stalder JF; Le Gall D
    Appl Neuropsychol Child; 2014; 3(2):94-102. PubMed ID: 24716868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding nonliteral language abilities in children with neurofibromatosis type 1.
    Haebich KM; Pride NA; Collins A; Porter M; Anderson V; Maier A; Darke H; North KN; Payne JM
    Neuropsychology; 2023 Nov; 37(8):872-882. PubMed ID: 37384446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An examination of lexical and sublexical reading skills in children with neurofibromatosis type 1.
    Watt SE; Shores A; North KN
    Child Neuropsychol; 2008 Sep; 14(5):401-18. PubMed ID: 17963094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor impairment in children with Neurofibromatosis type 1: Effect of the comorbidity with language disorders.
    Iannuzzi S; Albaret JM; Chignac C; Faure-Marie N; Barry I; Karsenty C; Chaix Y
    Brain Dev; 2016 Feb; 38(2):181-7. PubMed ID: 26321374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of ADHD on the cognitive and academic functioning of children with NF1.
    Pride NA; Payne JM; North KN
    Dev Neuropsychol; 2012; 37(7):590-600. PubMed ID: 23066937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological level.
    Hachon C; Iannuzzi S; Chaix Y
    Brain Dev; 2011 Jan; 33(1):52-61. PubMed ID: 20106617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliteracy impairments in children with neurofibromatosis type 1.
    Arnold SS; Payne JM; Lorenzo J; North KN; Barton B
    Dev Med Child Neurol; 2018 Jul; 60(7):703-710. PubMed ID: 29667706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of cognitive development in children with neurofibromatosis type 1 and plexiform neurofibromas.
    Hou Y; Allen T; Wolters PL; Toledo-Tamula MA; Martin S; Baldwin A; Reda S; Gillespie A; Goodwin A; Widemann BC
    Dev Med Child Neurol; 2020 Aug; 62(8):977-984. PubMed ID: 32052421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1.
    Payne JM; Haebich KM; MacKenzie R; Walsh KS; Hearps SJC; Coghill D; Barton B; Pride NA; Ullrich NJ; Tonsgard JH; Viskochil D; Schorry EK; Klesse L; Fisher MJ; Gutmann DH; Rosser T; Packer RJ; Korf B; Acosta MT; Bellgrove MA; North KN
    J Atten Disord; 2021 Jun; 25(8):1177-1186. PubMed ID: 31838937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.